Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 ChimerixPhaseBio PharmaceuticalsTapImmuneAptorum GroupAravive
SymbolNASDAQ:CMRXNASDAQ:PHASNASDAQ:MRKRNASDAQ:APMNASDAQ:ARAV
Price Information
Current Price$3.34$4.44$2.75$3.16$12.77
52 Week RangeBuyBuyBuyN/ABuy
Beat the Market™ Rank
Overall Score2.11.41.20.51.6
Analysis Score3.53.53.40.03.5
Community Score2.42.32.42.52.5
Dividend Score0.00.00.00.00.0
Ownership Score4.01.00.00.02.0
Earnings & Valuation Score0.60.00.00.00.0
Analyst Ratings
Consensus RecommendationBuyBuyBuyN/ABuy
Consensus Price Target$7.00$11.00$9.08N/A$26.00
% Upside from Price Target109.58% upside147.75% upside230.30% upsideN/A103.60% upside
Trade Information
Market Cap$206.85 million$127.79 million$127.97 million$91.55 million$203.67 million
Beta1.81.760.640.123.58
Average Volume2,477,633261,788794,42019,745165,170
Sales & Book Value
Annual Revenue$12.52 million$2.36 million$210,000.00$540,000.00$4.75 million
Price / Sales16.5254.15609.32169.5242.88
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$1.63 per share$1.86 per share$0.85 per share$0.51 per share$3.70 per share
Price / Book2.052.393.246.203.45
Profitability
Net Income$-112,580,000.00$-39,250,000.00$-21,430,000.00$-18,690,000.00$-18,220,000.00
EPS($0.86)($1.43)($0.47)N/A($1.57)
Trailing P/E RatioN/AN/AN/A0.00N/A
Forward P/E RatioN/AN/AN/A∞N/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-923.87%-2,310.60%N/AN/AN/A
Return on Equity (ROE)-34.16%-70.50%-49.42%N/A-37.54%
Return on Assets (ROA)-31.11%-54.65%-46.19%N/A-30.30%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.23%0.01%0.43%0.12%
Current Ratio15.98%9.68%13.27%3.00%12.36%
Quick Ratio15.98%9.68%13.27%2.99%12.36%
Ownership Information
Institutional Ownership Percentage51.43%67.44%33.14%N/A39.73%
Insider Ownership Percentage9.40%17.00%30.90%N/A39.80%
Miscellaneous
Employees8240113914
Shares Outstanding61.93 million28.78 million46.53 million28.97 million15.95 million
Next Earnings Date8/13/2020 (Estimated)8/11/2020 (Estimated)8/13/2020 (Estimated)7/29/2020 (Estimated)8/5/2020 (Estimated)
OptionableOptionableNot OptionableOptionableNot OptionableOptionable
Comparison Ideas:
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.